Open original FDA record ↗Recall record
- FDA identifier
- Z-1088-2009
- Company in FDA record
- Biosite Inc
- FDA classification date
- Mar 17, 2009
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
The recall was initiated after the firm's investigations confirmed that, while lot #186625 passed all internal specifications and quality requirements, the incidence of false positive PCP results has exceeded their post market surveillance thresholds for customer complaints in the field. In addition, the firm has been able to reproduce false positive results reported by customers and as a result
Source facts
- Action
- Consignee notification was initiated on 11/6/2008 with Urgent Medical Device Recall notifications, dated 11/5/2008 and mailed to domestic customers sent via US Postal Service Priority Mail and to foreign customers via FedEx. The notice informed customers of the reason for the recall and requested the customers immediately discontinue all use of lot #186625 and discard all affected product in accordance with your local regulations. The customers were also instructed to complete and fax an attached Customer/Distributor Verification form within 10 days.
- Initiated
- 2008-11-06
- Root cause
- Other
- Terminated
- 2011-10-13
- Distribution
- Worldwide Distribution -- USA and country of Canada.
- Recall number
- Z-1088-2009
- Recall status
- Terminated
- CDRH record ID
- 75998
- FDA classified
- 2009-03-17
- Recall event number
- 50689